Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
$3.12
-0.2%
$3.12
$1.53
$3.14
$280.83M0.4726,287 shs900 shs
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$59.14
+1.1%
$41.72
$30.33
$71.33
$174.29M0.722,831 shs9,667 shs
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
$11.89
+0.6%
$2.78
$2.10
$7.00
$28.72M1.07112,188 shs4,228 shs
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$0.00
$0.00
$0.60
$1K1.175,900 shs29 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
0.00%0.00%0.00%0.00%0.00%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
-2.43%-0.75%+48.14%+75.99%+35.23%
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
+0.30%+0.34%+3.66%+24.67%+11.73%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00%0.00%0.00%-66.67%-99.94%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
N/AN/AN/AN/AN/AN/AN/AN/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
1.3932 of 5 stars
0.02.00.80.02.61.71.3
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
0.00
N/AN/AN/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
0.00
N/AN/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
0.00
N/AN/AN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
$189.12M1.48$0.17 per share18.81$0.83 per share3.76
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$240.47M0.72$7.25 per share8.16$23.21 per share2.55
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
$9.67M2.97N/AN/A$3.11 per share3.82
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$9.61M0.00N/AN/A($0.99) per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
-$970K-$0.01N/AN/A-0.68%5.82%2.73%N/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$11.40M$3.8315.44N/A4.74%26.02%9.87%9/9/2025 (Estimated)
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
-$39.72M-$3.60N/A1,188.76N/A-98.84%-77.30%-37.75%N/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
-$17.98M-$5.14N/AN/AN/AN/AN/AN/AN/A

Latest KOOL, THMO, KEQU, and HEOFF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/25/2025Q4 2025
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
N/A$1.95N/A$1.63N/A$77.15 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
N/AN/AN/AN/AN/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$0.761.29%N/A19.84%N/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
N/A0.50%N/AN/AN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
0.55
2.10
1.50
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
0.92
2.20
1.59
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
0.50
1.52
0.91
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
N/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
32.69%
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
3.11%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
5.78%

Insider Ownership

CompanyInsider Ownership
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
4.89%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
14.20%
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
68.90%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
78.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
H2O Innovation Inc. stock logo
HEOFF
H2O Innovation
1,05590.01 million85.61 millionNot Optionable
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
1,2392.95 million2.53 millionNot Optionable
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
532.42 millionN/ANot Optionable
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
407.95 million1.75 millionNot Optionable

Recent News About These Companies

North American Morning Briefing: Stock Futures, -2-
Why Is ThermoGenesis (THMO) Stock Down 37% Today?
ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings Recent Insider Activity
ThermoGenesis Q3 Earnings Preview
Here's what Wall Street expects from ThermoGenesis's earnings report
ThermoGenesis Holdings Inc THMO
ThermoGenesis Holdings Earnings Preview

New MarketBeat Followers Over Time

Media Sentiment Over Time

H2O Innovation stock logo

H2O Innovation OTCMKTS:HEOFF

$3.12 -0.01 (-0.23%)
As of 12/11/2023

H2O Innovation Inc. designs and provides integrated water treatment solutions based on membrane filtration technology. It operates through three segments: Water Technologies and Services, Specialty Products, and Operation and Maintenance Services. The company offers membrane filtration technology for municipal, industrial, energy, and natural resources end-users; and aftersales services, as well as digital solutions to monitor and optimize water treatment plants. Its products include the FiberFlex open-source technologies for water treatment systems; the flexMBR for wastewater treatment systems; SILO system for wastewater and water reuse treatment; and FlexBox, a mobile fleet of water and wastewater treatment systems, such as containerized ultrafiltration or reverse osmosis (RO) systems. The company also offers specialty chemicals, consumables, and specialized products for the water industry, including RO membrane chemicals, such as antiscalants, flocculants, biocides, and cleaning chemicals; corrosion resistant equipment for desalination plants; flexible grooved-end couplings, fiberglass reinforced polyester cartridge filter housings, self-cleaning disc and screen filters, bag filters, cartridges, and strainers; and maple farming equipment. In addition, it operates, maintains, and repairs water and wastewater treatment systems, distribution equipment, and associated assets. The company was incorporated in 1995 and is headquartered in Quebec City, Canada. As of December 8, 2023, H2O Innovation Inc. was taken private.

Kewaunee Scientific stock logo

Kewaunee Scientific NASDAQ:KEQU

$59.14 +0.64 (+1.09%)
Closing price 04:00 PM Eastern
Extended Trading
$58.96 -0.19 (-0.31%)
As of 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

Cesca Therapeutics stock logo

Cesca Therapeutics NASDAQ:KOOL

Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. It offers AutoXpress System, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood; Point-of-CareXpress System, a proprietary automated device and companion sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow; CAR-TXpress System, a suite of multi-component automated system that allows the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology; BioArchive System, an automated cryogenic device for single-cassette based cryo-storage of biological license applications products; and manual bag sets for use in the processing and cryogenic storage of cord blood. The company is also developing autologous stem cell-based therapies that address medical needs for applications in the vascular, cardiology, and orthopedic markets. In addition, it provides cell manufacturing and banking services. The company was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California. Cesca Therapeutics Inc. is a subsidiary of Boyalife (Hong Kong) Limited.

ThermoGenesis stock logo

ThermoGenesis NASDAQ:THMO

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.